review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0002-9394(14)73518-4 |
P698 | PubMed publication ID | 8420359 |
P2093 | author name string | S J Ryan | |
P2860 | cites work | Angiogenic factors | Q29620582 |
Retinal pigment epithelial cells produce PDGF-like proteins and secrete them into their media | Q30460352 | ||
Combined posterior contusion and penetrating injury in the pig eye. II. Histological features | Q33642309 | ||
Combined posterior contusion and penetrating injury in the pig eye. III. A controlled treatment trial of vitrectomy | Q33642544 | ||
Experimental posterior penetrating eye injury in the rabbit. I. Method of production and natural history | Q33651343 | ||
Experimental posterior penetrating eye injury in the rabbit. II. Histology of wound, vitreous, and retina | Q33651348 | ||
Experimental posterior penetrating eye injury in the rhesus monkey: vitreous-lens admixture | Q33652201 | ||
An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes | Q33862469 | ||
Reoperation following diabetic vitrectomy | Q35995242 | ||
Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration | Q36015882 | ||
Demonstration of vasoproliferative activity from mammalian retina | Q36201178 | ||
Intraoperative argon endophotocoagulation for recurrent vitreous hemorrhage after vitrectomy for diabetic retinopathy. | Q36482916 | ||
Prognostic value of vitreous findings in diabetic retinopathy | Q36654103 | ||
Growth factors in the eye. | Q37806103 | ||
Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place? | Q37922620 | ||
Diabetic dense premacular hemorrhage. A possible indication for prompt vitrectomy | Q38396062 | ||
Pars plana vitrectomy techniques for relief of epiretinal traction by membrane segmentation | Q39572290 | ||
Pathogenesis of proliferative neovascular retinopathies and the role of vitrectomy. A hypothesis | Q39596809 | ||
Method of Production and Natural History of Experimental Posterior Penetrating eye Injury in the Rhesus Monkey | Q39681074 | ||
Timing of vitrectomy for active proliferative diabetic retinopathy | Q41468300 | ||
Ultrastructure of traction retinal detachment in rhesus monkey eyes after a posterior penetrating ocular injury. | Q41648196 | ||
Long-term results of vitrectomy and perfluorocarbon gas for the treatment of severe proliferative vitreoretinopathy | Q43551067 | ||
Results and prognostic factors in vitrectomy for diabetic traction-rhegmatogenous retinal detachment | Q44179375 | ||
Rupture of the Globe | Q44326858 | ||
Silicone oil for progressive anterior ocular neovascularization after failed diabetic vitrectomy | Q44337400 | ||
Macrophage modulation of retinal pigment epithelial cell migration and proliferation | Q46080681 | ||
Classification of proliferative vitreoretinopathy used in the silicone study. The Silicone Study Group | Q46206390 | ||
Methods, statistical features, and baseline results of a standardized, multicentered ophthalmologic surgical trial: The silicone study | Q46209197 | ||
The Use of Liquid Silicone in Retinal Detachment Surgery | Q54509339 | ||
Immunohistologic Study of Epiretinal Membranes in Proliferative Vitreoretinopathy | Q57693445 | ||
Cytokines in proliferative vitreoretinopathy | Q63407755 | ||
Pars Plana Vitrectomy in Ocular Trauma | Q66936958 | ||
Guidelines in the management of penetrating ocular trauma with emphasis on the role and timing of pars plana vitrectomy | Q67007803 | ||
A new concept for vitreous surgery. I. Instrumentation | Q67268527 | ||
Vitrectomy for Complications of Diabetic Retinopathy | Q67285234 | ||
Basic Fibroblast Growth Factor Levels in the Vitreous of Patients With Proliferative Diabetic Retinopathy | Q67660782 | ||
Perfluoro-octane in the Treatment of Giant Retinal Tears with Proliferative Vitreoretinopathy | Q67873038 | ||
An updated classification of retinal detachment with proliferative vitreoretinopathy | Q67938098 | ||
Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 1 | Q68140147 | ||
Retinal pigment epithelial cells produce fibronectin | Q68229136 | ||
Mechanisms involved in retinal pigment epithelial cell chemotaxis | Q68954264 | ||
Pars plana vitrectomy for severe penetrating injury with posterior segment involvement | Q68980322 | ||
Results and prognostic factors in vitrectomy for diabetic traction retinal detachment of the macula | Q68990347 | ||
Changing indications and techniques for vitrectomy in management of complications of diabetic retinopathy | Q69006169 | ||
Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction | Q69035039 | ||
Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 3. The Diabetic Retinopathy Vitrectomy Study Research Group | Q69054847 | ||
Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Clinical application of results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 4. The Diabetic Retinopathy Vitrectomy Study Research Grou | Q69054851 | ||
Long-term diabetic vitrectomy results. Report of 10 year follow-up | Q69383919 | ||
Vitrectomy for progressive macular traction associated with proliferative diabetic retinopathy | Q69463739 | ||
Proliferative vitreoretinopathy membranes. An immunohistochemical study | Q69513422 | ||
Cytoskeleton, adhesion, and extracellular matrix of fetal human retinal pigmented epithelial cells in culture | Q69592243 | ||
Results of vitrectomy for diabetic traction retinal detachments using the en bloc excision technique | Q69643100 | ||
Results and prognostic factors in vitrectomy for diabetic vitreous hemorrhage | Q69743322 | ||
Cryotherapy enhances intravitreal dispersion of viable retinal pigment epithelial cells | Q70069106 | ||
Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells | Q70083229 | ||
Proteins of the extracellular matrix in vitreoretinal membranes | Q70214667 | ||
Surgical results in ocular trauma involving the posterior segment | Q70327906 | ||
Early vitrectomy in the management of the severely traumatized eye | Q70362684 | ||
A comparison of different cellular inocula in an experimental model of massive periretinal proliferation | Q70362693 | ||
Effect of fibrin on morphologic characteristics of retinal pigment epithelial cells | Q70379814 | ||
Effect of vitreous on morphologic characteristics of retinal pigment epithelial cells. A new approach to the study of proliferative vitreoretinopathy | Q70580542 | ||
Timing of vitrectomy after penetrating ocular injuries | Q70656221 | ||
Serum contains chemoattractants for human retinal pigment epithelial cells | Q70701795 | ||
Proliferative vitreoretinopathy: the rabbit cell injection model for screening of antiproliferative drugs | Q70785893 | ||
Closed Vitrectomy in the Management of Diabetic Traction Retinal Detachment | Q70805818 | ||
Mechanisms in Traction Retinal Detachment | Q70871536 | ||
Pars Plana Vitrectomy for Diabetic Traction Retinal Detachment | Q70885402 | ||
Vitrectomy for Proliferative Diabetic Retinopathy Associated with Vitreous Hemorrhage | Q70885405 | ||
Control of experimental massive periretinal proliferation by daunomycin: dose-response relation | Q71067804 | ||
Penetrating ocular injuries. Types of injuries and visual results | Q71174758 | ||
Pars plana vitrectomy for complicated retinal detachments | Q71174760 | ||
Posterior vitreous detachment in diabetic subjects | Q71221068 | ||
Factors influencing final visual results in severely injured eyes | Q71380227 | ||
The lens influence on diabetic vitrectomy results. Report of a prospective randomized study | Q71429180 | ||
The natural history of diabetic extramacular traction retinal detachment | Q71466520 | ||
Vitrectomy in penetrating eye injury. Results of a controlled trial of vitrectomy in an experimental posterior penetrating eye injury in the rhesus monkey | Q71504158 | ||
The classification of retinal detachment with proliferative vitreoretinopathy | Q71748348 | ||
Vitreous contraction in proliferative diabetic retinopathy | Q72602729 | ||
The Effect of Lensectomy on the Incidence of Iris Neovascularization and Neovascular Glaucoma After Vitrectomy for Diabetic Retinopathy | Q72685861 | ||
Vitrectomy for Diabetic Traction Retinal Detachment Involving the Macula | Q72685866 | ||
Vitrectomy for diabetic rhegmatogenous retinal detachment | Q72685869 | ||
Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy | Q72731604 | ||
Biomicroscopic study of vitreous cavity in diabetic retinopathy | Q72760854 | ||
Two-year course of visual acuity in severe proliferative diabetic retinopathy with conventional management. Diabetic Retinopathy Vitrectomy Study (DRVS) report #1 | Q93559753 | ||
The pathophysiology of proliferative vitreoretinopathy in its management | Q93588666 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1-20 | |
P577 | publication date | 1993-01-01 | |
P1433 | published in | American Journal of Ophthalmology | Q4744258 |
P1476 | title | Traction retinal detachment. XLIX Edward Jackson Memorial Lecture | |
P478 | volume | 115 |
Q35679523 | A novel strategy to develop therapeutic approaches to prevent proliferative vitreoretinopathy |
Q35582614 | Aqueous and alcoholic extracts of Triphala and their active compounds chebulagic acid and chebulinic acid prevented epithelial to mesenchymal transition in retinal pigment epithelial cells, by inhibiting SMAD-3 phosphorylation |
Q44123219 | Basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in vitreous fluid from eyes with retinal detachment complicated by proliferative vitreoretinopathy |
Q49500666 | Cigarette smoke-induced EGFR activation promotes epithelial mesenchymal migration of human retinal pigment epithelial cells through regulation of the FAK-mediated Syk/Src pathway |
Q33788729 | Controversies in the management of open-globe injuries involving the posterior segment |
Q36716589 | Direct cyclopexy for traumatic cyclodialysis with persisting hypotony. Report in 29 consecutive patients |
Q41257017 | Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy |
Q44405556 | Elevated proto-oncogene and collagen mRNA expression in PVR retinas |
Q34427717 | Enhanced PKCδ and ERK signaling mediate cell migration of retinal pigment epithelial cells synergistically induced by HGF and EGF. |
Q42688238 | Epiretinal membrane and cystoid macular edema as predictive factors of recurrent proliferative vitreoretinopathy |
Q63407604 | Evidence of chronic inflammation in retina excised after relaxing retinotomy for anterior proliferative vitreoretinopathy |
Q54597157 | Evidence of cross-link formation of vitreous collagen during experimental ocular inflammation. |
Q35221367 | Expression of PDGFRα is a determinant of the PVR potential of ARPE19 cells |
Q39898210 | Growth factors outside of the platelet-derived growth factor (PDGF) family employ reactive oxygen species/Src family kinases to activate PDGF receptor alpha and thereby promote proliferation and survival of cells |
Q33557530 | Growth factors outside the PDGF family drive experimental PVR. |
Q47401527 | Histopathological and ophthalmoscopic evaluation of apocynin on experimental proliferative vitreoretinopathy in rabbit eyes. |
Q53066761 | In vitro vitamin K3 effect on conjunctival fibroblast migration and proliferation. |
Q36008844 | Inhibition of DNA Methylation and Methyl-CpG-Binding Protein 2 Suppresses RPE Transdifferentiation: Relevance to Proliferative Vitreoretinopathy |
Q41526638 | N-acetylcysteine suppresses retinal detachment in an experimental model of proliferative vitreoretinopathy |
Q37315556 | Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal disease |
Q41012721 | Orbital sonography in children |
Q43116460 | PDGF receptors are activated in human epiretinal membranes |
Q36164555 | Plasmin is the major protease responsible for processing PDGF-C in the vitreous of patients with proliferative vitreoretinopathy |
Q44047478 | Posterior vitreous findings in cases of spontaneous retinal reattachment |
Q77689407 | Primary vitrectomy for rhegmatogenous retinal detachment associated with choroidal detachment |
Q77144020 | Proliferative vitreoretinopathy: an overview |
Q34572836 | Proliferative vitreoretinopathy: risk factors and pathobiology |
Q74151965 | Retinal detachment after posterior segment intraocular foreign body injuries |
Q74429379 | Risk factors for proliferative vitreoretinopathy |
Q46917842 | Risk factors for recurrent retinal detachment |
Q43653223 | Shaken not stirred |
Q73251170 | Surgical management of traumatic retinal detachment with perfluorocarbon liquid. The Vitreon Study Group |
Q103804621 | Topical delivery of a small molecule RUNX1 transcription factor inhibitor for the treatment of proliferative vitreoretinopathy |
Q35943908 | Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses |
Q28250638 | Vascular endothelial growth factor and fibroblast growth factor 5 are colocalized in vascular and avascular epiretinal membranes |
Q43093684 | Vitreous levels of intercellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy |